Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT03191877
Other study ID # H-06-KM-001
Secondary ID
Status Recruiting
Phase N/A
First received June 9, 2017
Last updated January 8, 2018
Start date January 9, 2018
Est. completion date June 30, 2018

Study information

Verified date June 2017
Source Armed Forces Hospitals, Southern Region, Saudi Arabia
Contact Mufareh Asiri, SBOG
Phone 00966553725252
Email dr.mufareh@yahoo.com
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Randomized controlled trial in Obstetrics and Gynecology department (MULTI-CENTRIC).To measure the effect of coffee consumption on intestinal motility after caesarean section for the patient who fulfills the criteria. Then they will be randomized to 3 groups. The primary outcome and secondary outcome will be measured.


Description:

Randomized controlled trial. Participants who fulfill the inclusion criteria (elective caesarian section, singleton pregnancy, term, viable fetus), and exclusion criteria (medical disorders, known intestinal diseases, past history of intestinal surgery, intraoperative diagnosis of extensive adhesion, intraoperative complications "e.g., intestinal injury and ureteric injury intraoperative complication that can lengthen the operation time, postoperative complications like anesthesia complication and electrolytes imbalance ) Then they will be randomized to 3 groups. Group 1, will start to drink coffee 6 hours postoperative for maximum 3 doses (100ml), 8 hours apart, diet will start after 1st audible bowel sound.

Group 2, will drink water 6 hours postoperative. Diet will start after 1st audible bowel sound.

Group 3 is the control group and they will be (NOTHING PER ORAL) for 24 hours on intravenous fluid (3 LITRES/24 HOURS). Diet will start after 1st audible bowel sound.

Primary outcome: passage of stool. Secondary outcome: passage of flatus, audible intestinal sound time, feeding time, pain scale by Visual Analogue Scale (VAS), amount, and type of analgesia needed, breastfeeding time, mobilization and hospital stay.


Recruitment information / eligibility

Status Recruiting
Enrollment 600
Est. completion date June 30, 2018
Est. primary completion date May 30, 2018
Accepts healthy volunteers No
Gender Female
Age group 18 Years to 45 Years
Eligibility Inclusion Criteria:

- elective caesarian section, singleton pregnancy, term, viable fetus

Exclusion Criteria:

- medical disorders, known intestinal diseases, past history of intestinal surgery, intraoperative diagnosis of extensive adhesion, intraoperative complications "e.g., intestinal injury and ureteric injury intraoperative complication that can lengthen the operation time, postoperative complications like anesthesia complication and electrolytes imbalance )

Study Design


Related Conditions & MeSH terms


Intervention

Dietary Supplement:
coffee
Nescafe "brand of coffee made by Nestlé", red mug 100 % pure coffee 12083811

Locations

Country Name City State
Saudi Arabia AFHSR Khamis Mushait Abha

Sponsors (1)

Lead Sponsor Collaborator
Armed Forces Hospitals, Southern Region, Saudi Arabia

Country where clinical trial is conducted

Saudi Arabia, 

Outcome

Type Measure Description Time frame Safety issue
Primary passage of stool. passage of stool within 72 hours. (time to be recorded by 24-hour clock from finishing of surgery) 72 hours
Secondary Passage of flatus. . The amount of analgesia. The first Breastfeeding time. The initiation of Mobilization. Hospital length stay. (time to be recorded by the 24-hour clock from finishing of surgery). 72 hours
Secondary Audible intestinal sound time. Audible first intestinal sound time.(time to be recorded by the 24-hour clock from finishing of surgery). 72 hours
Secondary Feeding time Feeding time (StARTING OF REGULAR DIET ).(time to be recorded by the 24-hour clock from finishing of surgery). 72 hours
Secondary Pain scale by VAS (Visual Analogue Scale ). Pain scale by using Visual Analogue Scale(VAS). it is measuring the distance (mm) on the 10-cm line between the "no pain" anchor and the patient's mark, providing a range of scores from 0-100.
No pain (0-4 mm), mild pain (5-44 mm), moderate pain (45-74 mm), and severe pain (75- 100 mm).
72 hours
Secondary Type of analgesia needed. Type of analgesia needed. (paracetamol, nonsteroidal anti-inflammatory drugs or pethidine ). 72 hours
Secondary The amount of analgesia . ( recording of dose and frequency in time are mandatory ). 72 hours
Secondary The first Breastfeeding time. (time to be recorded by 24-hour clock from finishing of surgery) 72 hours
Secondary The initiation of Mobilization. (time to be recorded by 24-hour clock from finishing of surgery) 72 hours
Secondary Hospital length stay. ( in Days ) 72 hours
See also
  Status Clinical Trial Phase
Enrolling by invitation NCT01468428 - Small Intestinal Function in Patients With Cystic Fibrosis N/A
Completed NCT01159002 - Evaluation of Gastrointestinal Motility With SmartPill N/A
Recruiting NCT05933096 - Contrast-enhanced Multispectral Optoacoustic Tomography for Functional Assessment of the Gastrointestinal Transit N/A
Completed NCT01158989 - Clinical Evaluation Gastrointestinal Motility With PillCam N/A
Recruiting NCT06320613 - Effect of Implementing Snap-needle Therapy Combined With Ginger Paste During Anesthesia Recovery on the Recovery of Gastrointestinal Function After Gynecologic Laparoscopy N/A
Not yet recruiting NCT03841578 - Dark Chocolate and Intestinal Motility N/A
Completed NCT00468091 - Effects of Exendin(9-39) on Gastroduodenal Motility Phase 1
Completed NCT01366560 - Effect of GSK962040 on Oesophageal Function Phase 1
Completed NCT01635491 - Gastrointestinal Transit Times and Motility in Healthy Volunteers Obtained by Motilis-3D-transit N/A